Lipocine Inc.
LPCN
$2.11
$0.052.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.90% | -96.90% | -232.99% | -43.63% | 28.12% |
| Total Depreciation and Amortization | -9.32% | -5.13% | -3.85% | 65.88% | 89.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -120.45% | -342.19% | 41.99% | 109.73% | 420.83% |
| Change in Net Operating Assets | -251.94% | 1,178.37% | -656.87% | 139.50% | -52.33% |
| Cash from Operations | -60.56% | -14.61% | -271.54% | -5.39% | 24.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -67.01% | -1,022.79% | 103.83% | -36.38% | -5.31% |
| Cash from Investing | -67.01% | -1,022.79% | 106.50% | -31.40% | -5.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,894.31% | -- | -- | -- | -63.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,894.31% | -- | -- | -- | -65.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.35% | 93.33% | -47.02% | -18.37% | 8.79% |